Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer

INTRODUCTION: Following growing evidence to support the safety, local control (LC) and potential improvement in overall survival (OS) in patients with oligometastatic non-small cell lung cancer (NSCLC) that have been treated with local ablative therapy such as stereotactic ablative radiotherapy (SAB...

Descripción completa

Detalles Bibliográficos
Autores principales: Conibear, John, Chia, Brendan, Ngai, Yenting, Bates, Andrew Tom, Counsell, Nicholas, Patel, Rushil, Eaton, David, Faivre-Finn, Corinne, Fenwick, John, Forster, Martin, Hanna, Gerard G, Harden, Susan, Mayles, Philip, Moinuddin, Syed, Landau, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905762/
https://www.ncbi.nlm.nih.gov/pubmed/29666135
http://dx.doi.org/10.1136/bmjopen-2017-020690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905762/
https://www.ncbi.nlm.nih.gov/pubmed/29666135
http://dx.doi.org/10.1136/bmjopen-2017-020690

Ejemplares similares